Researcher.Life Logo

Nervno-Myshechnye Bolezni : Impact Factor & More

eISSN: 2413-0443pISSN: 2222-8721
JournalOpen Access

Key Metrics

CiteScore
0.5
SJR
Q4Neurology
SNIP
0.25
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Nervno-Myshechnye Bolezni

Nervno-Myshechnye Bolezni Journal Specifications

Overview
Publisher ABV-press Publishing house, LLC
Language Russian
Publication Time8
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageRussian
Society/Institute/SponsorAssociation of Neuromuscular Disorders Specialists (Russia)
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 8
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicyPreprint and Postprint Policy
License typeCC BY
OA statementVisit website
View less

Planning to publish in Nervno-Myshechnye Bolezni ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Nervno-Myshechnye Bolezni

Neuroimaging in hereditary neuromuscular disorders: a literature review and clinical case reports
  • 24 Dec 2025
  • Neuromuscular Diseases
Clinical features of fatigue in amyotrophic lateral sclerosis
  • 26 Apr 2025
  • Neuromuscular Diseases
Phenotype expansion, or double trouble: the combination of congenital disorder of glycosylation type 1i and Joubert syndrome type 17
  • 26 Apr 2025
  • Neuromuscular Diseases
Assessment of social emotional, cognitive and communicative development and adaptive behavior in children with spinal muscular atrophy 5q
  • 26 Apr 2025
  • Neuromuscular Diseases
Overlap of myasthenia gravis, myocarditis, and inflammatory myopathy secondary to immune checkpoint inhibitor (pembrolizumab) on a background of previously undiagnosed thymoma-associated acetylcholine receptor antibody-positive myasthenia gravis
  • 26 Apr 2025
  • Neuromuscular Diseases
Results of rehabilitation of myasthenia gravis patients with subclinical respiratory disturbances
  • 26 Apr 2025
  • Neuromuscular Diseases
Neuroimaging in hereditary neuromuscular disorders: a literature review and clinical case reports
  • 24 Dec 2025
  • Neuromuscular Diseases
Clinical features of fatigue in amyotrophic lateral sclerosis
  • 26 Apr 2025
  • Neuromuscular Diseases
Phenotype expansion, or double trouble: the combination of congenital disorder of glycosylation type 1i and Joubert syndrome type 17
  • 26 Apr 2025
  • Neuromuscular Diseases
Assessment of social emotional, cognitive and communicative development and adaptive behavior in children with spinal muscular atrophy 5q
  • 26 Apr 2025
  • Neuromuscular Diseases
Overlap of myasthenia gravis, myocarditis, and inflammatory myopathy secondary to immune checkpoint inhibitor (pembrolizumab) on a background of previously undiagnosed thymoma-associated acetylcholine receptor antibody-positive myasthenia gravis
  • 26 Apr 2025
  • Neuromuscular Diseases
Results of rehabilitation of myasthenia gravis patients with subclinical respiratory disturbances
  • 26 Apr 2025
  • Neuromuscular Diseases

FAQs on Nervno-Myshechnye Bolezni